Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Jacob

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Blood|February 28, 2002
Clinical and biologic features of CD4(+)CD56(+) malignanciesJean Feuillard, Marie-Christine Jacob, Françoise Valensi, et al.
BMJ Open|June 18, 2024
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy studyCharlotte Planta, Caroline Bret, Delphine Manzoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemiaAaron D Schimmer, Elihu H Estey, Gautam Borthakur, et al.
Blood|September 25, 2004
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cellsFrancine Garnache-Ottou, Laurence Chaperot, Sabeha Biichle, et al.
Human Molecular Genetics|January 17, 2009
The Aurora Kinase C c.144delC mutation causes meiosis I arrest in men and is frequent in the North African populationKlaus Dieterich, Raoudha Zouari, Radu Harbuz, et al.
Cancers|December 10, 2021
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCLAntonin Bouroumeau, Lucile Bussot, Sieme Hamaidia, et al.
Leukemia|September 16, 2020
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemiaRémi Letestu, Abdelmalek Dahmani, Marouane Boubaya, et al.
Haematologica|October 6, 2018
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromesSophie Park, Olivier Kosmider, Frédéric Maloisel, et al.
Blood|April 10, 2016
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasmsAnouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 1, 2019
Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group ExperienceFrançoise Solly, Fanny Angelot-Delettre, Michel Ticchioni, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Blood|February 28, 2002
Clinical and biologic features of CD4(+)CD56(+) malignanciesJean Feuillard, Marie-Christine Jacob, Françoise Valensi, et al.
BMJ Open|June 18, 2024
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy studyCharlotte Planta, Caroline Bret, Delphine Manzoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemiaAaron D Schimmer, Elihu H Estey, Gautam Borthakur, et al.
Blood|September 25, 2004
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cellsFrancine Garnache-Ottou, Laurence Chaperot, Sabeha Biichle, et al.
Human Molecular Genetics|January 17, 2009
The Aurora Kinase C c.144delC mutation causes meiosis I arrest in men and is frequent in the North African populationKlaus Dieterich, Raoudha Zouari, Radu Harbuz, et al.
Cancers|December 10, 2021
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCLAntonin Bouroumeau, Lucile Bussot, Sieme Hamaidia, et al.
Leukemia|September 16, 2020
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemiaRémi Letestu, Abdelmalek Dahmani, Marouane Boubaya, et al.
Haematologica|October 6, 2018
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromesSophie Park, Olivier Kosmider, Frédéric Maloisel, et al.
Blood|April 10, 2016
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasmsAnouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 1, 2019
Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group ExperienceFrançoise Solly, Fanny Angelot-Delettre, Michel Ticchioni, et al.
Pageof 9